Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
dDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan eLaboratory for Molecular Mechanisms of Brain Development, RIKEN Center for ...
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and ...
Livdelzi belongs to a class of drugs called peroxisome proliferator-activated receptor-delta agonists and is designed to reduce the production of bile acid in the liver, preventing liver damage and ...
Infection is the invasion by and multiplication of 'foreign' microorganisms that can cause pathological conditions or diseases in the host organism. CD8 + T cell exhaustion is defined by a unique ...
It works by controlling liver problems in the body and making the liver less inflamed Seladelpar belongs to a group of medicines called peroxisome proliferator-activated receptor delta agonists. The ...
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback